Drug Trial Radar · NCT03245229
A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood)
Last checked: Nov 19, 2026Latest source record: Nov 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Aug 10, 2017
Primary completion
Sep 18, 2017
Study completion Sep 18, 2017
Sponsor
- Lead sponsor
- Idorsia Pharmaceuticals Ltd.Industry
- Sponsor type
- Industry
- First posted
- Aug 10, 2017
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to investigate the effect of Aprocitentan (ACT-132577) at steady state on the pharmacokinetics of single-dose rosuvastatin in healthy male subjects
Conditions
- Healthy Subjects
Interventions
AprocitentanDrug
Capsule for oral administration
RosuvastatinDrug
Tablet for oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum plasma concentration (Cmax) of rosuvastatinTime frame: Up to Day 29
- Time to reach Cmax (tmax) of rosuvastatinTime frame: Up to Day 29
- Terminal half-life (t1/2) of rosuvastatinTime frame: Up to Day 29
- Area under the plasma concentration-time curves during a dosing interval [AUC(0-t)] of rosuvastatinTime frame: Up to Day 29
- Area under the plasma concentration-time curves from time 0 to inf [AUC(0-inf)] of rosuvastatinTime frame: Up to Day 29
- Trough (pre-dose) plasma concentrations (Ctrough) of ACT-132577Time frame: Up to Day 29
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Cepha s.r.o
Pilsen, Czechia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.